Prognostic value of post-thyroidectomy thyroglobulin levels in patients with differentiated thyroid cancer

Journal of Endocrinological Investigation

Volumn 34, Issue 11, 2011, Pages 855-860

  Polachek, A ^a,b   Hirsch, D ^a,c   Tzvetov, G ^a,c   Grozinsky Glasberg, S ^a,c   Slutski, I ^a,c   Singer, J ^a,c   Weinstein, R ^a,c   Shimon, I ^a,c   Benbassat, C A ^a,c  

^a RABIN MEDICAL CENTER   (Israel)

^b ASSAF HAROFEH MEDICAL CENTER   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

Prognosis; Thyroglobulin; Thyroid cancer

Indexed keywords

IODINE; THYROGLOBULIN;

ABLATION THERAPY; ADULT; ARTICLE; CANCER INVASION; CANCER REGISTRY; CANCER SIZE; CANCER STAGING; CANCER SURGERY; DIFFERENTIATED THYROID CANCER; DISTANT METASTASIS; FEMALE; FOLLOW UP; HUMAN; IODINE ABLATION; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PREDICTIVE VALUE; PROGNOSIS; SENSITIVITY AND SPECIFICITY; THYROIDECTOMY;

ADULT; AGED; CELL DIFFERENTIATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; PROGNOSIS; PROSPECTIVE STUDIES; REGISTRIES; RETROSPECTIVE STUDIES; THYROGLOBULIN; THYROID NEOPLASMS; THYROIDECTOMY; TUMOR MARKERS, BIOLOGICAL;

EID: 84858055503     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.3275/7768     Document Type: Article

References (20)

1. Schlumberger MJ, Filetti S, Hay ID. Non toxic diffuse and nodular goiter and thyroid neoplasia. In: Kronenberg HM, Melmed S, Polonsky HS, Larsen PR editors. Williams textbook of endocrinology. Philadelphia: WB Saunders. 2008, 420-45.
2. Jemal A, Siegel R, Ward E, et al. Cancer statistics. CA Cancer J Clin 2006, 56: 106-30.
3. American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer; Cooper DS, Doherty GM, Haugen BR, et al. Revised american thyroid association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009, 19: 1167-214.
4. Eustatia-Rutten CF, Smit JW, Romijn JA, et al. Diagnostic value of serum thyroglobulin measurments in the follow-up of differentiated thyroid carcinoma, a structured meta analysis. Clin Endocrinol (Oxf) 2004, 61: 61-74. (Pubitemid 38951647)
5. Mazzaferri EL, Robbins RJ, Spencer CA, et al. A consensus report of the role of serum thryglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma. J Clin Endocrinol Metab 2003, 88: 1433-41. (Pubitemid 36623351)
6. Smallridge RC, Meek SE, Morgan MA, et al. Monitoring thyroglobulin in a sensitive immunoassay has comparable sensitivity to recombinant human TSH-stimulated thyroglobulin in follow-up of thyroid cancer patients. J Clin Endocrinol Metab 2007, 92: 82-7. (Pubitemid 46075007)
7. Rosario PW, Purisch S. Does a highly sensitive throglobulin (Tg) assay change the clinical management of low risk patients with thyroid cancer with Tg on T4<1 ng/ml determined by traditional assays?. Clin Endocrinol (Oxf) 2008, 68: 338-42. (Pubitemid 351257849)
8. Giovanella L, Ceriani L, Ghelfo A, et al. Thyroglobulin assay during thyroxine treatment in low risk differentiated thyroid cancer management. Comparison with recombinant human thyrotropin-stmuliated assay and imaging procedures. Clin Chem Lab Med 2006, 44: 648-52. (Pubitemid 43735641)
9. Schlumberger M, Hitzel A, Toubert ME, et al. Comparison of seven serum thyroglobulin assays in the follow-up of papillary and follicular thyroid cancer patients. J Clin Endocrinol Metab 2007, 92: 2487-95. (Pubitemid 47037347)
10. Iervasi A, Iervasi G, Ferdeghini M, et al. Clinical relevance of highly sensitive Tg assay in monitoring patients treated for differentiated thyroid cancer. Clin Endocrinol (Oxf) 2007, 67: 434-41. (Pubitemid 47283844)
11. Grunwald F, Menzel C, Fimmers R, Zamora PO, Biersack HJ. Prognostic value of thyroglobulin after thyroidectomy before ablative radioiodine therapy in thyroid cancer. J Nuc Med 1996, 37: 1962-4. (Pubitemid 26428362)
12. Verkooijen RB, Rietbergen D, Smit JW, Romijn JA, Stokkel MP. A new functional parameter measured at the time of ablation that can be used to predict differentiated thyroid cancer recurrence during follow up. Eur J Endocrinol 2007, 156: 41-7. (Pubitemid 46553902)
13. Giovanella L, Ceriani L, Suriano S, Ghelfo A, Maffioli M. Thyroglobulin measurement before rhTSH-aided 131I ablation in detecting metastasis from differentiated thyroid carcinoma. Clin Endocrinol 2008, 69: 659-63.
14. Huang SH, Wang PW, Huang YE, et al. Sequential follow-up of serum thyroglobulin and whole body scan in thyroid cancer patients without initial metastasis. Thyroid 2006, 16: 1273-8.
15. Giovanella L, Ceriani L, Ghelfo A, Keller F. Thyroglobulin assay 4 weeks after thyroidectomy predicts outcome in low-risk papillary thyroid carcinoma. Clin Chem Lab Med 2005, 43: 843-7. (Pubitemid 41461160)
16. Kim TY, Kim WB, Kim ES, et al. Serum thyroglobulin levels at the time of 131I remnant ablation just after thyroidectomy are useful for early prediction of clinical recurrence in low risk patients with differentiated thyroid carcinoma. J Clin Endocrinol Metab 2005, 90: 1440-5.
17. Heemstra KE, Liu YY, Stokel M, et al. Serum thyroglobulin concentrations predict disease-free remission and death in differentiated thyroid cancer. Clin Endocrinol (Oxf) 2007, 66: 58-64. (Pubitemid 44952495)
18. Lin JD, Huang MJ, Hsu BR-S, et al. Significance of postoperative serum thyroglobulin levels in patients with papillary and follicular thyroid carcinomas. J Surg Oncol 2002, 80: 45-51. (Pubitemid 34477735)
19. th ed. New York: Springer-Verlag 2002.
20. Schlumberger M, Berg G, Cohen O, Duntas L, Jamar F, Jarzab B. Follow-up of low-risk patients with differentiated thyroid carcinoma: a European perspective. Eur J Endocrinol 2004, 150: 105-12. (Pubitemid 38312801)